Unknown

Dataset Information

0

Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa.


ABSTRACT: Herlitz junctional epidermolysis bullosa (H-JEB) is an incurable, devastating, and mostly fatal inherited skin disease for which there is only supportive care. H-JEB is caused by loss-of-function mutations in LAMA3, LAMB3, or LAMC2, leading to complete loss of laminin 332, the major component of anchoring filaments, which mediate epidermal-dermal adherence. LAMB3 (laminin ?3) mutations account for 80% of patients with H-JEB, and ?95% of H-JEB-associated LAMB3 mutations are nonsense mutations leading to premature termination codons (PTCs). In this study, we evaluated the ability of gentamicin to induce PTC readthrough in H-JEB laminin ?3-null keratinocytes transfected with expression vectors encoding eight different LAMB3 nonsense mutations. We found that gentamicin induced PTC readthrough in all eight nonsense mutations tested. We next used lentiviral vectors to generate stably transduced H-JEB cells with the R635X and C290X nonsense mutations. Incubation of these cell lines with various concentrations of gentamicin resulted in the synthesis and secretion of full-length laminin ?3 in a dose-dependent and sustained manner. Importantly, the gentamicin-induced laminin ?3 led to the restoration of laminin 332 assembly, secretion, and deposition within the dermal/epidermal junction, as well as proper polarization of ?6?4 integrin in basal keratinocytes, as assessed by immunoblot analysis, immunofluorescent microscopy, and an in vitro 3D skin equivalent model. Finally, newly restored laminin 332 corrected the abnormal cellular phenotype of H-JEB cells by reversing abnormal cell morphology, poor growth potential, poor cell-substratum adhesion, and hypermotility. Therefore, gentamicin may offer a therapy for H-JEB and other inherited skin diseases caused by PTC mutations.

SUBMITTER: Lincoln V 

PROVIDER: S-EPMC6048497 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gentamicin induces <i>LAMB3</i> nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa.

Lincoln Vadim V   Cogan Jon J   Hou Yingping Y   Hirsch Michaela M   Hao Michelle M   Alexeev Vitali V   De Luca Michele M   De Rosa Laura L   Bauer Johann W JW   Woodley David T DT   Chen Mei M  

Proceedings of the National Academy of Sciences of the United States of America 20180626 28


Herlitz junctional epidermolysis bullosa (H-JEB) is an incurable, devastating, and mostly fatal inherited skin disease for which there is only supportive care. H-JEB is caused by loss-of-function mutations in <i>LAMA3</i>, <i>LAMB3</i>, or <i>LAMC2</i>, leading to complete loss of laminin 332, the major component of anchoring filaments, which mediate epidermal-dermal adherence. <i>LAMB3</i> (laminin β3) mutations account for 80% of patients with H-JEB, and ∼95% of H-JEB-associated <i>LAMB3</i> m  ...[more]

Similar Datasets

| S-EPMC1288363 | biostudies-literature
| S-EPMC7565164 | biostudies-literature
| S-EPMC3010368 | biostudies-literature